Immunorestitution disease involving the innate and adaptive response

被引:160
作者
Cheng, VCC
Yuen, KY
Chan, WM
Wong, SSY
Ma, ESK
Chan, RMT
机构
[1] Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China
[2] Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
[3] Queen Mary Hosp, Intens Care Unit, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1086/313809
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunorestitution disease (IRD) is defined as an acute symptomatic or paradoxical deterioration of a (presumably) preexisting infection that is temporally related to the recovery of the immune system. We report the temporal sequence of events that led to IRD caused by Pneumocystis carinii and Aspergillus terreus in 2 human immunodeficiency virus (HIV)-negative patients soon after the recovery of adaptive and innate immunity, respectively, and we review episodes noted in the English-language literature that fit the definition of IRD (109 episodes in 107 patients). The median time from the recovery of neutrophil counts or termination of steroid therapy to the development of IRD was 8 days in cases of pulmonary aspergillosis (23 episodes) and hepatosplenic candidiasis (8) and 21 days for viral diseases such as hepatitis B (24) and viral pneumonitis (6), For IRD due to mycobacteriosis (27 episodes) and cryptococcosis (4) in HIV-positive patients, the median interval between the initiation of highly active antiretroviral therapy (HAART) and the onset of IRD was 11 days; for viral infections, including those due to cytomegalovirus (14), hepatitis B virus (1), and hepatitis C virus (2), the median interval was 42 days, As an emerging clinical entity, IRD merits further study to optimize treatment of immunosuppressed patients.
引用
收藏
页码:882 / 892
页数:11
相关论文
共 51 条
  • [1] ALBELDA SM, 1985, AM REV RESPIR DIS, V131, P115
  • [2] FLUCONAZOLE THERAPY FOR CHRONIC DISSEMINATED CANDIDIASIS IN PATIENTS WITH LEUKEMIA AND PRIOR AMPHOTERICIN-B THERAPY
    ANAISSIE, E
    BODEY, GP
    KANTARJIAN, H
    DAVID, C
    BARNETT, K
    BOW, E
    DEFELICE, R
    DOWNS, N
    FILE, T
    KARAM, G
    POTTS, D
    SHELTON, M
    SUGAR, A
    [J]. AMERICAN JOURNAL OF MEDICINE, 1991, 91 (02) : 142 - 150
  • [3] BIRD GLA, 1989, Q J MED, V73, P895
  • [4] Blanche P, 1998, SCAND J INFECT DIS, V30, P615, DOI 10.1080/00365549850161223
  • [5] CHRONIC SYSTEMIC CANDIDIASIS
    BODEY, GP
    ANAISSIE, EJ
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (10) : 855 - 857
  • [6] Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor
    Carr, A
    Cooper, DA
    [J]. LANCET, 1997, 349 (9057) : 995 - 996
  • [7] Hepatitis B associated liver failure following bone marrow transplantation
    Caselitz, M
    Link, H
    Hein, R
    Maschek, H
    Boker, K
    Poliwoda, H
    Manns, MP
    [J]. JOURNAL OF HEPATOLOGY, 1997, 27 (03) : 572 - 577
  • [8] Paradoxical reactions in HIV and pulmonary TB
    Chien, JW
    Johnson, JL
    [J]. CHEST, 1998, 114 (03) : 933 - 936
  • [9] Immune reconstitution in HIV infection
    Emery, S
    Lane, HC
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (04) : 568 - 572
  • [10] FULMINANT-HEPATITIS AS A CONSEQUENCE OF REACTIVATION OF HEPATITIS-B VIRUS-INFECTION AFTER DISCONTINUATION OF LOW-DOSE METHOTREXATE THERAPY
    FLOWERS, MA
    HEATHCOTE, J
    WANLESS, IR
    SHERMAN, M
    REYNOLDS, WJ
    CAMERON, RG
    LEVY, GA
    INMAN, RD
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 112 (05) : 381 - 382